Home/Filings/4/0001209191-19-004549
4//SEC Filing

Kirson Eilon D. 4

Accession 0001209191-19-004549

CIK 0001645113other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 4:13 PM ET

Size

15.0 KB

Accession

0001209191-19-004549

Insider Transaction Report

Form 4
Period: 2019-01-16
Kirson Eilon D.
Chief Science Officer
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2019-01-16$14.37/sh+100,000$1,437,000209,063 total
  • Exercise/Conversion

    Ordinary Shares

    2019-01-17$14.37/sh+68,813$988,843177,876 total
  • Sale

    Ordinary Shares

    2019-01-16$45.11/sh100,000$4,511,000109,063 total
  • Exercise/Conversion

    Options to Buy Ordinary Shares

    2019-01-16100,000135,335 total
    Exercise: $14.37Exp: 2025-02-23Ordinary Shares (100,000 underlying)
  • Exercise/Conversion

    Options to Buy Ordinary Shares

    2019-01-1768,81366,522 total
    Exercise: $14.37Exp: 2025-02-23Ordinary Shares (68,813 underlying)
  • Sale

    Ordinary Shares

    2019-01-17$45.25/sh68,813$3,113,788109,063 total
Footnotes (4)
  • [F1]Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson.
  • [F2]On January 16, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 100,000 shares in multiple trades at prices ranging from $45.00 to $45.36. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]On January 17, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 68,813 shares in multiple trades at prices ranging from $45.00 to $45.66. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]Fully vested and currently exercisable as of the date hereof.

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1
  • filerCIK 0001654356

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 4:13 PM ET
Size
15.0 KB